SINGULAR MEDICAL TECHNOLOGIES, INC.
WINTER HAVEN, FLORIDA

SINGULAR MEDICAL TECHNOLOGIES, INC., WINTER HAVEN

Co-Founder and Chairman of SMT, is a seasoned business executive, investor, entrepreneur, philanthropist, and hands-on turnaround specialist, has served as a board member and Chief Executive Officer of Life Care Medical Devices since 2013 (www.lcmd.com), and CEO of Prati Management, a small Family Office since 2012. LCMD is an innovative non-invasive company utilizing electromagnetic induction to target the aesthetics space and seeking to address multiple other conditions as well. Richard has over 20 years of proven financial leadership and operational execution in investment banking, institutional equity sales, and professional investment management. As a Principal at several notable Wall Street investment firms, Mr. Prati has a strong history of exceptional value creation and a successful track record of transformational, business turnaround expertise including sourcing and executing transactions, accessing the public and private markets and catalyzing sizable revenue growth production. He has guided a wide range of emerging and established public and private entities in industries ranging from healthcare, biotech, medical devices, conglomerates, retail, industrials, information technology and semiconductors companies. Mr. Prati serves as a Director of KNOW-BIO, an innovative platform technology utilizing Nitric Oxide to address a wide range of medical conditions including respiratory ailments such as Cystic Fibrosis as well as attempting to address superbugs and excessive use of antibiotics. Mr. Prati also recently served as Vice Chairman of PVG Asset Management (www.pvgassetmanagement.com), a fund family with nearly $1 Billion in assets for three years, and is a board member and early-stage investor of the privately-held Centennial Brands company. In 2002 Mr. Prati was one of two co-founders of American Technology Research (AmTech), an independent research broker/dealer and negotiated the $35 million sale of AmTech to Broadpoint in 2008. He then served as President and Vice Chairman of the equities division of Gleacher and Company (GLCH, which merged with Broadpoint AmTech shortly after the acquisition of AmTech). In 2010, Mr. Prati accepted the position Senior Managing Director of Equities at Sterne Agee, a large regional brokerage-firm that was recently acquired by Stifel Nicolaus. Prior to founding AmTech, Mr. Prati was a Senior Partner at SoundView Technology Group, ran the west coast and launched the Denver office as well as establishing firm records as the top revenue producer his final three years. Richard served as an Executive Director at SG Warburg (UBS) in institutional equity sales, after embarking on his successful Wall Street career as an investment banker at Dean Witter Reynolds (acquired by Morgan Stanley). He earned his MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester and his B.S in Economics from Vanderbilt University. has more than 30 years of technology investment banking and equity trading experience. Since 2012, he’s been Managing Director of Trading and an Operating Committee member at MKM Partners. He has an extensive background in public and private equity investments ranging from technology and medical devices to biotech and consumer companies. Prior to MKM Partners, Mr. Brown was one of three co-founders of American Technology Research (AmTech), an independent research broker/dealer, where he built and managed AmTech’s trading infrastructure and sales trading desk. Brown subsequently served as Managing Director of Sales Trading of Gleacher & Co., which merged with Broadpoint AmTech shortly after the acquisition. In 1995, he joined Soundview Technology Group, a technology investment banking, and research boutique firm, as a Managing Director and top sales trader until his departure to AmTech in 2002. Prior to Soundview, Mr. Brown served as a Vice President at Merrill Lynch from 1987 to 1995. He earned his B.S. in Marketing and Economics from Old Dominion University. In addition to his current position with KNOW Bio – which is focused on developing therapeutic nitric oxide solutions for diseases like cystic fibrosis – Hunter co-founded Cree in the late 1980’s and served as CEO until 2001. In 2005, he launched LED Lighting Fixtures to introduce LED lighting for general illumination. That company was acquired in 2008. He then became Novan's founding investor and Chairman where he spearheaded raising more than $100 million in private financing to develop that company’s line of unique nitric oxide-based solutions. He served in that position until 2016 when he helped launch KNOW Bio. He earned his degree in mechanical engineering from N.C. State. In addition to his current position with KNOW Bio – which is focused on developing therapeutic nitric oxide solutions for diseases like cystic fibrosis – Hunter co-founded Cree in the late 1980’s and served as CEO until 2001. In 2005, he launched LED Lighting Fixtures to introduce LED lighting for general illumination. That company was acquired in 2008. He then became Novan's founding investor and Chairman where he spearheaded raising more than $100 million in private financing to develop that company’s line of unique nitric oxide-based solutions. He served in that position until 2016 when he helped launch KNOW Bio. He earned his degree in mechanical engineering from N.C. State. “Our radiology group provides coverage for nine hospitals in central and west Florida, and we believed it was critical to implement a neuroradiology subspecialty service for all sites from a central location. Unfortunately, the hospitals use different PACS and as such it was very difficult for me to read for all facilities in any way that was practical. Instead of playing musical chairs in a gymnasium filled with numerous workstations and multiple monitors for each and every work station, Singular Medical Technologies designed and developed an elegant solution that brings all the sites together into one beautiful setup without delays or lag-time. The technology even has superior functionality compared to me working at the specific onsite PACS stations themselves. I can finally read neuro studies for our entire practice just like I was sitting at each facility. Awesome job! Thank you Singular!”

KEY FACTS ABOUT SINGULAR MEDICAL TECHNOLOGIES, INC.

Company name
SINGULAR MEDICAL TECHNOLOGIES, INC.
Status
Inactive
Filed Number
F15000004845
FEI Number
320473584
Date of Incorporation
November 2, 2015
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://singularmedicaltechnologies.com
Phones
(855) 378-5843

SINGULAR MEDICAL TECHNOLOGIES, INC. NEAR ME

Principal Address
5999 DUNDEE ROAD SUITE 100,
WINTER HAVEN,
FL,
33884,
US

See Also

Officers and Directors

The SINGULAR MEDICAL TECHNOLOGIES, INC. managed by the three persons from WINTER HAVEN on following positions: CIO, Dire

Felix Garcia

Position
CIO Active
From
WINTER HAVEN, 33884

John Adair

Position
Dire Active
From
WINTER HAVEN, 33884

Richard Ajr. Brown

Position
Dire Active
From
WINTER HAVEN, 33884





Registered Agent is Felix I Garcia

From
WINTER HAVEN, 33884

Events

September 25, 2020
REVOKED FOR ANNUAL REPORT
November 10, 2015
ARTICLES OF CORRECTION

Annual Reports

2019
April 5, 2019
2018
March 28, 2018